Allergan Gets MHRA Approval for Botox in UK

infogrok.com — Allergan has said that Botox (botulinum toxin type A) has been licensed by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK for the prophylaxis of headaches in adults who have chronic migrain. Jul 10, 2010 View in Crawl 4